Anti-Tumor Necrosis Factor With a Glyco-Engineered Fc-Region Has Increased Efficacy in Mice With Colitis

Author(s):
Bloemendaal, F.M.; Levin, A.D.; Wildenberg, M.E.; Koelink, P.J.; McRae, B.L.; Salfeld, J.; Lum, J.; Kolfschoten, M.V.; Claassens, J.W.; Visser, R.; Bentlage, A.; D'Haens, G.R.A.M.; Verbeek, J.S.; Vidarsson, G.; Brink, G.R. van den
Published
2017
Publication type
Article / Letter to editor
Crohn's DiseaseFc gamma ReceptorDrug ModificationMouse Model
Date issued
2017-11-30
Language
English
Is part of
Gastroenterology (2017), Vol. 153, no. 5, p. 1351-+
hdl
1887/94948
doi
10.1053/j.gastro.2017.07.021